Coherus Oncology Inc (CHRS)

Cash & Short-Term Investments

$105.31M

Quarterly · Period ending: · USD

CHRS logo

CHRS Cash & Short-Term Investments

Latest reported$105.31M
CHRS Quarterly Cash & Short-Term Investments ($14.55M → $105.31M)
High-resolution chart · PNG

CHRS cash & short-term investments history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Coherus Oncology Inc Cash & Short-Term Investments — Quarterly (USD)
Period endingCash & Short-Term Investments (USD)
105,306,000
167,048,000
172,125,000
191,663,000
237,637,000
82,411,000
125,987,000
97,690,000
159,240,000
259,775,000
117,748,000
131,529,000
145,152,000
128,529,000
191,681,000
286,805,000
275,484,000
325,680,000
417,195,000
468,707,000
454,421,000
399,503,000
541,158,000
503,431,000
456,499,000
193,252,000
177,668,000
170,493,000
111,918,000
96,433,000
72,356,000
117,170,000
159,818,000
95,164,000
126,911,000
150,050,000
118,332,000
174,824,000
124,947,000
159,677,000
220,916,000
179,558,000
158,226,000
153,691,000
206,088,000
115,136,000
150,392,000
100,875,000
108,869,000
56,317,000
39,554,000
14,548,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.